Welcome to our dedicated page for Scotts Miracle Gr SEC filings (Ticker: SMG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Scotts Miracle-Gro Company (NYSE: SMG) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its operations, governance and financial condition. As an Ohio‑incorporated issuer with common shares listed on the New York Stock Exchange, ScottsMiracle-Gro uses periodic reports and current reports to describe its branded consumer lawn and garden business, indoor and hydroponic growing operations and related financing arrangements.
On this page, you can review core filings such as the annual report on Form 10‑K and quarterly reports on Form 10‑Q, which include segment information for U.S. Consumer, Hawthorne and Other, along with discussions of risk factors, liquidity, capital resources and segment performance. These filings also elaborate on topics referenced in company news releases, such as gross margin trends, leverage, free cash flow and the role of credit facilities and receivables programs in the capital structure.
Current reports on Form 8‑K provide more targeted updates. Recent 8‑K filings describe a Seventh Amended and Restated Credit Agreement establishing senior secured loan facilities, amendments to a master receivables purchase agreement, results of operations for specific quarters and changes to the board of directors and equity award documentation. These filings outline key terms such as leverage and interest coverage covenants, security packages and the use of proceeds for working capital and general corporate purposes.
Definitive proxy statements on Schedule 14A offer detail on corporate governance and executive compensation. ScottsMiracle-Gro’s proxy materials cover board composition, committee responsibilities, director independence, say‑on‑pay proposals, long‑term incentive plan terms, stock ownership guidelines and severance and change‑in‑control arrangements.
This filings page combines real‑time access to new EDGAR submissions with AI‑generated summaries that explain the structure and implications of each document. Users can quickly identify items such as 10‑K and 10‑Q reports, 8‑K current reports, proxy statements and exhibits related to credit agreements or incentive plans, and use the summaries to focus on the sections most relevant to their analysis of SMG.
The Scotts Miracle-Gro Company director reports additional derivative equity units. A reporting person serving as a director of The Scotts Miracle-Gro Company (SMG) filed a Form 4 disclosing a derivative equity transaction dated 12/05/2025. The filing shows an acquisition of 159 dividend equivalent rights, which are linked to previously granted deferred stock units (DSUs) or restricted stock units (RSUs).
According to the disclosure, each dividend equivalent right is the economic equivalent of one common share of Scotts Miracle-Gro and becomes exercisable proportionately with the related DSUs or RSUs. Following this transaction, the reporting person beneficially owns 948 derivative securities tied to common shares on a direct basis. This reflects routine equity-based compensation activity rather than a cash transaction.
The Scotts Miracle-Gro Company director reports routine equity-based compensation activity. A company director filed a Form 4 disclosing the acquisition of 42 dividend equivalent rights tied to existing deferred stock units (DSUs) or restricted stock units (RSUs) on 12/05/2025. After this transaction, the reporting person holds 150 derivative securities directly. The filing explains that each dividend equivalent right is economically equal to one common share of Scotts Miracle-Gro and vests proportionately with the related DSUs or RSUs, reflecting ongoing alignment of director compensation with shareholder interests rather than a cash transaction.
Scotts Miracle-Gro director reports dividend-equivalent award
A director of Scotts Miracle-Gro Co. reported a routine equity-related transaction involving derivative securities. On 12/05/2025, the reporting person acquired 187 dividend equivalent rights, recorded as an "A" (acquired) transaction. These rights are tied to existing deferred stock unit (DSU) or restricted stock unit (RSU) grants and become exercisable proportionately with the underlying DSUs or RSUs.
Each dividend equivalent right is described as the economic equivalent of one common share of Scotts Miracle-Gro. Following this transaction, the reporting person beneficially owned 1,210 derivative securities on a direct basis, reflecting ongoing participation in the company’s equity-based compensation programs rather than a change in control or role.
Scotts Miracle-Gro Chairman and CEO James Hagedorn, who is also a director and 10% owner, reported acquiring additional derivative equity in the form of phantom stock. On 12/05/2025, he received 2,751.65 shares of phantom stock, each representing the right to receive one common share of Scotts Miracle-Gro or the cash value of a share. Following this transaction, he beneficially owned 231,850.829 phantom stock units in total. These phantom stock shares are payable in cash after his employment with the company ends, and he may transfer the phantom stock into an alternative investment at any time.
The Scotts Miracle-Gro Company director reports routine equity-based compensation activity. A director of Scotts Miracle-Gro, identified in the signature block as Brian E. Sandoval, reported a transaction dated 12/05/2025 involving derivative securities tied to the company’s common shares. The filing shows the acquisition of 189 dividend equivalent rights related to existing deferred stock unit (DSU) or restricted stock unit (RSU) grants. Each dividend equivalent right is described as the economic equivalent of one common share of Scotts Miracle-Gro.
Following this transaction, the reporting person beneficially owns 1,154 derivative securities in direct form. According to the explanation, these dividend equivalent rights accrue on DSU or RSU grants and become exercisable proportionately with the underlying awards, aligning the director’s economic interests with those of common shareholders.
The Scotts Miracle-Gro Company director Edith Aviles reported an equity-related transaction involving derivative securities. On 12/05/2025, she acquired 121 dividend equivalent rights tied to deferred stock units (DSUs) or restricted stock units (RSUs). Each dividend equivalent right is the economic equivalent of one common share of Scotts Miracle-Gro. Following this transaction, she held 783 derivative securities on a direct ownership basis. These awards track the value of common shares but are reported separately from standard stock holdings.
Scotts Miracle-Gro Company executive Christopher J. Hagedorn, who serves as EVP & Chief of Staff, reported a small increase in his direct ownership of company stock. On 11/28/2025, he acquired 4.693 common shares of Scotts Miracle-Gro at a price of $46.24 per share in a non-open-market transaction coded "J."
Following this transaction, Hagedorn now beneficially owns 60,106.7964 common shares of Scotts Miracle-Gro, held directly. The filing was made as a Form 4 for a single reporting person, documenting his updated ownership position for investors and regulators.
The Scotts Miracle-Gro Company Chairman and CEO James Hagedorn, who is also a director and more than 10% owner of SCOTTS MIRACLE-GRO CO (SMG), reported a small change in his holdings. On 11/28/2025, a transaction coded "J" added 43.253 common shares at a price of $46.24 per share to his directly held position.
After this transaction, Hagedorn beneficially owned 103,135.0688 common shares directly, plus 31,533.64 common shares held through a 401(k) plan and 997,910 common shares indirectly through Hagedorn Partnership, L.P., reflecting his proportionate and family-related interests. No derivative securities were reported in this filing.
The Scotts Miracle-Gro Company executive reports small share acquisition
A senior executive of The Scotts Miracle-Gro Company, serving as EVP, CFO & CAO, reported a minor change in his holdings of the company’s common shares. On 11/28/2025, he acquired 3.244 common shares at a price of $46.24 per share, reported under transaction code J, which is used for other types of acquisitions or transfers. Following this transaction, he beneficially owned 15,282.749 common shares in a direct account and 493.482 common shares through a 401(k) plan. This filing reflects routine insider ownership reporting rather than a major corporate event.
The Scotts Miracle-Gro Company Chairman and CEO James Hagedorn reported a compensation-related transaction involving phantom stock tied to the company’s common shares. On 11/26/2025, he acquired 1,595.606 phantom stock units at a reference price of $56.61 per unit. Each phantom share represents the right to receive one common share of Scotts Miracle-Gro or the cash value of a share.
The phantom stock is payable in cash after his employment with the company ends, and he may transfer these units into an alternative investment at any time. Following this transaction, Hagedorn beneficially owned 229,099.179 derivative securities directly, reflecting his ongoing equity-linked stake in the company.